Science.Online
Publisher and Institutes
Akademie Verlag
Deutsches Institut für Urbanistik
Oldenbourg Wissenschaftsverlag
Walter de Gruyter
Schattauer
You are here: Home :: Area NEM :: Medical science :: Human medicine
 
Carolina de Oliveira Gigek, Elizabeth Suchi Chen, Maysa Seabra Cendoroglo, Luiz Roberto Ramos, Lara M. Quirino Araujo, Spencer Luiz Marques Payo, Marlia de Arruda Cardoso Smith

Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels

Keywords: elderly, high-density lipoprotein, lipoprotein lipase, LPL HindIII polymorphism, LPL S447X polymorphism, myocardial infarction, triglyceride

Background: Lipoprotein lipase has an important role in lipid metabolism. Elevated levels of very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) are associated with increased risk of coronary artery disease and low levels of high-density lipoprotein (HDL) are potentially atherogenic. The HindIII and S447X polymorphisms of the lipoprotein lipase (LPL) gene are associated with cardiovascular disease in some populations.

Methods: LPL HindIII and S447X polymorphisms were analyzed in 343 individuals of 66–97 years of age from a cohort of a Brazilian elderly longitudinal study. Allele frequencies, genotype distribution and allele association with major morbidities and with serum lipid, urea, creatinine and albumin levels were also investigated. The whole sample was genotyped by PCR-restriction fragment length polymorphism (RFLP). Descriptive statistics, logistic regression analysis and t-test were used.

Results: Allele frequencies were H+=0.652 and H=0.348 for LPL HindIII and S=0.824 and X=0.176 for LPL S447X polymorphism. Both polymorphisms have frequencies similar to those in some European populations. LPL HindIII polymorphism showed significant association of the H+ allele with myocardial infarction. The H allele showed a tendency to associate with higher HDL levels. The LPL S447X S allele was associated with higher triglyceride levels.

Conclusions: These findings may help to identify risk factors for subjects and families and clarify the physiopathological role of these polymorphisms in age-related diseases.

Clin Chem Lab Med 2007;45:599–604.

Clinical Chemical Laboratory Medicine, Walter de Gruyter

Print ISSN: 1434-6621
Volume: 45, 05/2007
Pages: 599 - 604

Show full article (external site)

Show all available items of this journal